Back to Hematology
Hematologyv2011 SpyropoulosEvidence-Based

IMPROVE Risk Score for Venous Thromboembolism (VTE)

Predicts 3-month risk of acute venous thromboembolism (VTE) in hospitalized medical patients. The IMPROVE (International Medical Prevention Registry on Venous Thromboembolism) Predictive score was developed to assess VTE risk in hospitalized medical patients and help identify patients who may not require pharmacological thromboprophylaxis. This validated clinical prediction tool uses 7 clinical variables present at admission or during hospitalization to stratify patients into risk categories. Patients with scores <2 (representing <1% 3-month VTE risk) may not warrant pharmacologic thromboprophylaxis, while those with scores ≥2 should receive prophylaxis. The score is particularly valuable for identifying low-risk medical patients who can safely avoid anticoagulation.

Clinical Input Parameters

Clinical Assessment
Awaiting Parameters
score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The IMPROVE Risk Score for Venous Thromboembolism (VTE) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within hematology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Score = Previous VTE (3) + Known thrombophilia (2) + Current lower-limb paralysis (2) + Current cancer (2) + Immobilized ≥7 days (1) + ICU/CCU stay (1) + Age >60 years (1)

Clinical Pearls & Practice Notes

  • Developed from international IMPROVE database of hospitalized medical patients
  • Score <2 indicates pharmacologic thromboprophylaxis not warranted (<1% 3-month VTE risk)
  • Score ≥2 indicates need for pharmacologic or mechanical prophylaxis
  • Previous VTE carries highest risk weight (3 points) due to high recurrence rates
  • Thrombophilia and paralysis each carry 2 points, reflecting significant VTE risk
  • Cancer diagnosis adds 2 points regardless of type or stage
  • Immobilization defined as ≥7 days immediately prior to and during admission
  • ICU/CCU stay reflects severe illness and procedural VTE risks
  • Age >60 years threshold based on increased baseline VTE risk
  • Score validated in multiple external cohorts with consistent performance
  • Consider bleeding risk assessment (e.g., IMPROVE Bleeding Risk Score) before anticoagulation
  • May be combined with bleeding risk scores for comprehensive risk-benefit analysis
  • Mechanical prophylaxis alternatives for high bleeding risk patients
  • Score should be reassessed if clinical status changes during hospitalization

Evidence & Literature Citations

  1. Spyropoulos AC, Anderson FA Jr, FitzGerald G, et al. Predictive and associative models to identify hospitalized medical patients at risk for VTE. Chest. 2011 Sep;140(3):706-714. doi: 10.1378/chest.10-1944.
  2. Hostler DC, Marx ES, Moores LK, et al. Validation of the International Medical Prevention Registry on Venous Thromboembolism bleeding risk model. Chest. 2016 Apr;149(4):1002-1009. doi: 10.1378/chest.15-2082.
  3. Rosenberg D, Eichorn A, Alarcon M, et al. External validation of the risk assessment model of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) for medical patients in a tertiary health system. J Am Heart Assoc. 2014 Nov 4;3(6):e001152. doi: 10.1161/JAHA.114.001152.

Score Interpretation Ranges

Very Low Risk0 – 0 pts

Score 0 points

Low Risk1 – 1 pts

Score 1 point

Moderate Risk2 – 2 pts

Score 2 points

Moderate-High Risk3 – 3 pts

Score 3 points

High Risk4 – 4 pts

Score 4 points

Very High Risk5 – 12 pts

Score 5-12 points

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.